[The use of the antiepileptic drug trileptal in the clinical practice].
The data on therapeutical efficacy of the new antiepileptic drug trileptal (oxcarbazepine) and results of the own observations of 38 patients with partial epilepsy who received trileptal as mono- or polytherapy are presented. The high efficacy and good tolerability of the drug has been shown. The seizure control has been obtained in 84% of patients.